Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James P. Boylan currently holds 18,500 shares of Compass Therapeutics, Inc. (CMPX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James P. Boylan has been a net neutral trader of CMPX stock. They have purchased $0 and sold $0 worth of shares.
James P. Boylan's most recent insider trade was on Jun 15, 2026, when they sold 18,500 shares at $0.00 per share.
James P. Boylan serves as Executive at Compass Therapeutics, Inc. (CMPX). They have executed 5 insider transactions totaling $0 over their tenure at the company.
James P. Boylan holds the position of Executive at Compass Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
James P. Boylan has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by James P. Boylan was on Jun 15, 2026, when they purchased $0 worth of ZBIO shares. This transaction involved 18,500 shares at N/A per share.
James P. Boylan currently owns 18,500 shares of Compass Therapeutics, Inc. (CMPX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James P. Boylan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James P. Boylan has 5 Form 4 filings on record as an insider at Compass Therapeutics, Inc..
Set alerts for James P. Boylan and 40,000+ other insiders.